ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

FUSN Fusion Pharmaceuticals Inc

21.44
-0.05 (-0.23%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Fusion Pharmaceuticals Inc FUSN NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.05 -0.23% 21.44 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
21.50 21.43 21.51 21.45 21.49
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202412:56PRNUSKuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to..
25/4/202415:34PRNUSFusion Pharmaceuticals Mails Circular for Special Meeting of..
09/4/202415:05PRNCAFusion Pharmaceuticals Announces Presentation of Interim..
20/3/202415:10PRNUSKuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to..
20/3/202415:05PRNCAFusion Pharmaceuticals Reports Fourth Quarter and Full Year..
19/3/202402:00PRNUSFusion Pharmaceuticals to be Acquired by AstraZeneca,..
06/3/202406:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/3/202415:43PRNUSFusion Pharmaceuticals to Present Interim Data from the..
26/2/202406:45PRNCAFusion Pharmaceuticals to Present at Upcoming March Investor..
16/2/202415:05EDGAR2Form 8-K - Current report
16/2/202407:45PRNUSFusion Pharmaceuticals Enters into Exclusive Worldwide..
07/2/202406:45PRNUSFusion Pharmaceuticals to Present at the Oppenheimer 34th..
06/2/202415:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
19/1/202415:13EDGAR2Form 8-K - Current report
19/1/202415:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/1/202407:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202407:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202407:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202407:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202405:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
04/1/202417:53DJNShares of Fusion Pharmaceuticals Rise 7.8% With Study..
04/1/202415:31EDGAR2Form 8-K - Current report
04/1/202415:05PRNUSFusion Pharmaceuticals Announces Clinical Program and..
16/11/202305:45BWBWXT Medical Expands Collaboration with Fusion..
08/11/202315:15PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
08/11/202307:15PRNCAFusion Pharmaceuticals to Present at Upcoming Investor..
07/11/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:45EDGAR2Form 8-K - Current report
07/11/202306:00PRNCAFusion Pharmaceuticals Announces Third Quarter 2023..
16/10/202315:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202315:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/10/202315:30EDGAR2Form 8-K - Current report
16/10/202306:50PRNCAFusion Pharmaceuticals Appoints Life Science Industry..
12/10/202306:45PRNUSFusion Pharmaceuticals Announces Presentation of Preclinical..
06/9/202315:25PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
05/9/202315:10PRNCAFusion Pharmaceuticals to Present at Upcoming September..
09/8/202315:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
08/8/202307:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:30EDGAR2Form 8-K - Current report
08/8/202306:00PRNUSFusion Pharmaceuticals Announces Second Quarter 2023..
06/7/202315:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
26/6/202307:05PRNCAFusion Pharmaceuticals to Present Interim Data from Phase 1..
16/6/202307:05PRNCAFusion Pharmaceuticals to Present at the TD Cowen..
07/6/202306:35PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
31/5/202315:10PRNUSFusion Pharmaceuticals to Present at the Jefferies..
11/5/202306:15PRNUSFusion Pharmaceuticals Announces First Quarter 2023..
09/5/202306:45PRNUSFusion Pharmaceuticals to Present at the Guggenheim..

Su Consulta Reciente

Delayed Upgrade Clock